Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

677
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
677
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.1K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.1K
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

289
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
289
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

510
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
510
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.2K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.2K
Coefficient of Correlation01:12

Coefficient of Correlation

8.9K
The correlation coefficient, r, developed by Karl Pearson in the early 1900s, is numerical and provides a measure of strength and direction of the linear association between the independent variable x and the dependent variable y.
If you suspect a linear relationship between x and y, then r can measure how strong the linear relationship is.
What the VALUE of r tells us:
The value of r is always between –1 and +1: –1 ≤ r ≤ 1.
The size of the correlation r indicates the...
8.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Xpert® bladder Cancer monitor urine test for non-muscle-invasive bladder cancer surveillance: a prospective clinical trial.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Craniofacial Asymmetric Patterns in Congenital Muscular Torticollis: A Computed Tomography-Based Visual Classification and Cluster Analysis With Clinical Implications.

The Journal of craniofacial surgery·2026
Same author

Evaluating fluctuating and directional asymmetry in postnatal petrous bone growth: a 3D morphometric study.

Surgical and radiologic anatomy : SRA·2026
Same author

The RaDiCo information system for rare disease cohorts.

Orphanet journal of rare diseases·2025
Same author

Parietal complications after cystectomy: Incisional and parastomal hernia, epidemiology and risk factors.

The French journal of urology·2024
Same author

Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study.

Vaccines·2023
Same journal

Integrating health economics and implementation science: a call to action.

BMC medical research methodology·2026
Same journal

Methods for incorporating test result information within the high-dimensional propensity score framework: application in UK electronic health record data.

BMC medical research methodology·2026
Same journal

Sparse multi-way DMDC for longitudinal classification in high dimension low sample size data.

BMC medical research methodology·2026
Same journal

Tree-based exploratory identification of predictive biomarkers in non-randomized data.

BMC medical research methodology·2026
Same journal

Comparative evaluation of interrupted time series analytical methods for healthcare quality improvement research: a Monte Carlo simulation study.

BMC medical research methodology·2026
Same journal

Methodological advances in claims-based dementia algorithms: integrating medication and clinical data for medicare populations.

BMC medical research methodology·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

On the censored cost-effectiveness analysis using copula information.

Charles Fontaine1, Jean-Pierre Daurès2, Paul Landais2

  • 1UPRES EA2415-Institut Universitaire de Recherche Clinique, Université de Montpellier, 641, Av. du doyen G.-Giraud, Montpellier, France. charles.fontaine@usherbrooke.ca.

BMC Medical Research Methodology
|February 17, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces a copula-based method for cost-effectiveness analysis (CEA) that accounts for censoring in therapeutic trials. The approach avoids linearity assumptions, reducing bias in estimating costs and quality-adjusted life years (QALYs).

Keywords:
Censored dataCopulasCost-effectiveness analysisParametric modelsSubgroups analysis

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

704
Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb
08:24

Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb

Published on: August 30, 2016

10.8K

Related Experiment Videos

Last Updated: Mar 7, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

704
Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb
08:24

Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb

Published on: August 30, 2016

10.8K

Area of Science:

  • Biostatistics
  • Health Economics
  • Medical Research

Background:

  • Understanding dependence between covariate distributions is crucial, especially in therapeutic trials where censoring can bias results.
  • Censoring in data can lead to biased interpretations of marginal distribution dependencies and joint probability distributions.
  • Cost-effectiveness analysis (CEA), widely used in medico-economic studies, frequently encounters censoring, posing challenges for accurate analysis.

Purpose of the Study:

  • To present a copula-based modeling approach for joint density estimation in CEA.
  • To develop an estimation method for costs and quality-adjusted life years (QALYs) that handles censoring.
  • To provide a method that does not rely on linearity assumptions for inferred variables.

Main Methods:

  • Utilized copula-based modeling to estimate joint density and key economic endpoints (costs, QALYs).
  • Employed punctual estimation derived from marginal distributions and their dependence structure.
  • Applied the method to a cost-effectiveness analysis in the presence of censored data.

Main Results:

  • The proposed methodology successfully reduces bias by eliminating reliance on unverified linearity assumptions.
  • Statistical inference bias is limited to inherent statistical uncertainties, not model assumptions.
  • An acupuncture study for chronic headache demonstrated the method's applicability, with the Incremental Cost-Effectiveness Ratio (ICER) falling within the standard regression confidence interval.

Conclusions:

  • This copula-based technique represents a significant advancement for cost-effectiveness literature by removing the need for global linear regression models.
  • The method requires only the estimation of marginal distributions, concordance measures, and appropriate copula families for complete CEA.
  • This approach offers a more robust and less assumption-dependent framework for conducting CEA in scenarios with censored data.